Malignancies after hematopoietic stem cell transplantation: Many questions, some answers

Blood

Volumn 91, Issue 6, 1998, Pages 1833-1844

  Deeg, H Joachim ^a   Socié, Gérard ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; AUTOTRANSPLANTATION; CANCER RISK; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MYELODYSPLASTIC SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOLID TUMOR; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA;

EID: 0032521217     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1833     Document Type: Review

References (134)

1. Deeg HJ: Delayed complications after bone marrow transplantation, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 538
2. Socie G, Kolb HJ: Malignant diseases after bone marrow transplantation: The case for tumor banking and continued reporting to registries. EBMT Late-Effects Working Party (editorial). Bone Marrow Transplant 16:493, 1995
3. Deeg HJ, Witherspoon RP: Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 7:417, 1993
4. The Committee for the Compilation of Materials on Damage Caused by the Atomic Bombs in Hiroshima and Nagasaki: Hiroshima and Nagasaki: The Physical, Medical, and Social Effects of the Atomic Bombings. New York, NY, Basic Books, 1981
5. Mole RH: Late effects of radiation: Carcinogenesis (review). Br Med Bull 29:78, 1973
6. Boice JD: Cancer following medical irradiation. Cancer 47:1081, 1981
7. Tucker MA, D'Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, Hoover RN, Fraumeni JF Jr: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588, 1987
8. Travis LB, Curtis RE, Stovall M, Holowaty EJ, Van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM, Gospodarowicz MK, Adami J, Wacholder S, Inskip PD, Tucker M, Boice JD: Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 86:1450, 1994
9. Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625, 1996
10. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughn Hudson B, MacLennan KA: Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 68:1006, 1993
11. Cohen JI: Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency (review). Medicine 70:137, 1991
12. Shapiro RS: Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: Meeting the challenge. J Clin Oncol 8:371, 1990
13. Seiden MV, Sklar J: Molecular genetic analysis of post-transplant lymphoproliferative disorders (review). Hematol Oncol Clin North Am 7:447, 1993
14. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080, 1989
15. Schwartz RS, Beldotti L: Malignant lymphomas following allogeneic disease: Transition from an immunological to a neoplastic disorder. Science 149:1511, 1965
16. Deeg HJ, Prentice R, Fritz TE, Sale GE, Lombard LS, Thomas ED, Storb R: Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. Int J Radiat Oncol Biol Phys 9:1505, 1983
17. Broerse JJ, Hollander CF, Van Zwieten MJ: Tumor induction in Rhesus monkeys after total body irradiation with X-rays and fission neutrons. Int J Radiat Biol 40:671, 1981
18. Kolb HJ, Rieder I, Bodenberger U, Netzel B, Schaffer E, Kolb H, Thierfelder S: Dose rate and dose fractionation studies in total body irradiation of dogs. Pathol Biol 27:370, 1979
19. Shepherd JD, Gascoyne RD, Barnett MJ, Coghlan JD, Phillips GL: Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant 15:639, 1995
20. Okada S, Nagayoshi K, Nakauchi H, Nishikawa S, Miura Y, Suda T: Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells. Blood 81:1720, 1993
21. Socie G, Kolb HJ, Ljungman P: Malignant diseases after allogeneic bone marrow transplantation: The case for assessment of risk factors (review). Br J Haematol 80:427, 1992
22. Socie G, Henry-Amar M, Devergie A, Esperou-Bourdeau H, Ribaud P, Traineau R, Gluckman E: Malignant diseases after allogeneic bone marrow transplantation: An updated overview (review). Nouv Rev Fr Hematol 36:S75, 1994 (suppl 1)
23. O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB: Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants, in De Vita TD, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1996. Philadelphia, PA, Lippincott-Raven, 1996, p 149
24. Witherspoon RP, Deeg HJ, Storb R: Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplantation 57:1413, 1994
25. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A, Gandjbakhch I, Binet JL, Raphael M: Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 13:961, 1995
26. List AF, Greco FA, Vogler LB: Lymphoproliferative diseases in immunocompromised hosts: The role of Epstein-Barr virus (review). J Clin Oncol 5:1673, 1987
27. Swinnen LJ: Post-transplantation lymphoproliferative disorder. Leuk Lymphoma 6:289, 1992
28. Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA: Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97:14, 1994
29. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI: Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723, 1990
30. Joncas JH, Russo P, Brochu P, Simard P, Brisebois J, Dube J, Marton D, Leclerc JM, Hume H, Rivard GE: Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 8:378, 1990
31. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ: Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47:293, 1989
32. Faure P, d'Agay MF, Tricot G, Gluckman E, Brocheriou C: Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction. Ann Pathol 6:137, 1986
33. Emanuel DJ, Lucas KG, Mallory GB Jr, Edwards-Brown MK, Pollok KE, Conrad PD, Robertson KA, Smith FO: Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes. Transplantation 63:1691, 1997
34. Bloom RE, Brennan JK, Sullivan JL, Chiganti RS, Dinsmore R, O'Reilly R: Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A. Am J Hematol 18:73, 1985
35. Gossett TC, Gale RP, Fleischman H, Austin GE, Sparkes RS, Taylor CR: Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N Engl J Med 300:904, 1979
36. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451, 1991
37. Simon M, Bartram CR, Friedrich W, Arnold R, Schmeiser T, Hampl W, Muller-Hermelink HK, Heymer B: Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study. Virchows Arch 60:307, 1991
38. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH: Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
39. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
40. Schubach WH, Hackman R, Neiman PE, Miller G, Thomas ED: A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood 60:180, 1982
41. Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, Robison LL, Miller JS, Neglia JP: Malignant neoplasms following bone marrow transplantation. Blood 87:3633, 1996
42. Davey DD, Kamat D, Laszewski M, Goeken JA, Kemp JD, Trigg ME, Purtilo DT, Davis J, Dick FR: Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: An immunologic and genotypic analysis. Mod Pathol 2:27, 1989
43. Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L, Haskins S, Heerema NA, Gharpure V, Abonour R, Srour EF, Cornetta K: Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol 107:419, 1997
44. Cleary ML, Nalesnik MA, Shearer WT, Sklar J: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349, 1988
45. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552, 1995
46. Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM: Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 147:1862, 1995
47. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185, 1994
48. Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H: Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 42:350, 1993
49. Suhrbier A, Burrows SR, Fernan A, Lavin MF, Baxter GD, Moss DJ: Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. J Immunol 150:2169, 1993
50. Cen H, Williams PA, McWilliams HP, Breinig MC, Ho M, McKnight JL: Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 81:1393, 1993
51. McKnight JL, Cen H, Riddler SA, Breinig MC, Williams PA, Ho M, Joseph PS: EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease (review). Leuk Lymphoma 15:9, 1994
52. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM: Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 327:1710, 1992
53. Delecluse HJ, Rouault JP, Ffrench M, Dureau G, Magaud JP, Berger F: Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours. Br J Haematol 89:90, 1995
54. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784, 1989
55. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by The National Marrow Donor Program. N Engl J Med 328:593, 1993
56. Hale G, Cobbold S, Waldmann H: T cell depletion with Campath-1 in allogeneic bone marrow transplantation. Transplantation 45:753, 1988
57. Ho M: Risk factors and pathogenesis of posttransplant lymphoproliferative disorders (review). Transplant Proc 27:38, 1995
58. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells (review). Cell 77:791, 1994
59. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396, 1995
60. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242, 1996
61. Klein C, Rothenberger S, Niemeyer C, Bachmann E, Odermatt B, Bohm N, Brandis M, Knecht H: EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene. Br J Haematol 91:938, 1995
62. Crawford DH, Mulholland N, Iliescu V, Hawkins R, Powles R: Epstein-Barr virus infection and immunity in bone marrow transplant recipients. Transplantation 42:50, 1986
63. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 87:2594, 1996
64. Lucas KG, Pollok KE, Emanuel DJ: Post-transplant EBV induced lymphoproliferative disorders (review). Leuk Lymphoma 25:1, 1997
65. Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ: Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 seid/seid mice. J Exp Med 183:1215, 1996
66. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2:551, 1996
67. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9, 1995
68. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE: Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 89:98, 1995
69. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA: Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60:547, 1995
70. Riddler SA, Breinig MC, McKnight JL: Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972, 1994
71. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C: Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715, 1994
72. Benkerrou M, Durandy A, Fischer A: Therapy for transplant-related lymphoproliferative diseases (review). Hematol Oncol Clin North Am 7:467, 1993
73. Sullivan JL, Medveczky P, Forman SJ, Baker SM, Monroe JE, Mulder C: Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy. N Engl J Med 311:1163, 1984
74. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI: Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86:3333, 1995
75. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A: Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin [letter]. N Engl J Med 318:1334, 1988
76. Blanche S, Le Deist F, Veber F, Lenoir G, Fischer AM, Brochier J, Boucheix C, Delaage M, Griscelli C, Fischer A: Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation. Ann Intern Med 108:199, 1988
77. Stephan JL, Le Deist F, Blanche S, Le Bidois J, Peuchmaur M, Lellouch-Tubiana A, Hirn M, Griscelli C, Fischer A: Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation 54:246, 1992
78. Durandy A, Brousse N, Rozenberg F, de Saint Basile G, Fischer AM, Fischer A: Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 90:945, 1992
79. Durandy A, Emilie D, Peuchmaur M, Forveille M, Clement C, Wijdenes J, Fischer A: Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J Immunol 152:5361, 1994
80. Tanner JE, Menezes J: Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. Blood 84:3956, 1994
81. Papadopoulos EB, Small T, Ladanyi M, Boulad F, Castro-Malaspina H, Childs B, Kernan N, Mackinnon S, Szabolcs P, Young J, O'Reilly RJ: Current results of donor leukocyte infusions for treatment of Epstein-Barr virus associated lymphoproliferative disorders following related and unrelated T cell depleted bone marrow transplant. Blood 88:681a, 1996 (abstr, suppl 1)
82. Heslop HE, Smith CA, Ng C, Loftin SK, Sixbey J, Krance RA, Brenner MK, Rooney CM: Efficacy of adoptively transferred virus specific cytotoxic T lymphocytes for prophylaxis and treatment of EBV lymphoma. Blood 88:681a, 1996 (abstr, suppl 1)
83. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C: HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719, 1997
84. Lieberman J, Buchsbaum RJ: Using T cells to treat B-cell cancers (editorial; comment). N Engl J Med 330:1231, 1994
85. Hanson MN, Morrison VA, Peterson BA, Stieglbauer KT, Kubic VL, McCormick SR, McGlennen RC, Manivel JC, Brunning RD, Litz CE: Posttransplant T-cell lymphoproliferative disorders - An aggressive, late complication of solid-organ transplantation. Blood 88:3626, 1996
86. van Gorp J, Doornewaard H, Verdonck LF, Klopping C, Vos PF, van den Tweel JG: Posttransplant T-cell lymphoma. Report of three cases and a review of the literature (review). Cancer 73:3064, 1994
87. Zutter MM, Durnam DM, Hackman RC, Loughran TP Jr, Kidd PG, Hanke D, Ashley RL, Petersdorf EW, Martin PJ, Thomas ED: Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol 94:714, 1990
88. Socie G: Secondary malignancies. Curr Opin Hematol 3:468, 1996
89. Meignin V, Devergie A, Brice P, Brison O, Ribaud P, Cojean I, Gluckman E, Socie G, Janin A: Late occurrence of Hodgkin's disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Transplantation (in press)
90. Verschuur A, Brousse N, Raynal B, Brison O, Rohrlich P, Rahimy C, Vilmer E: Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 14:467, 1994
91. Shustik C, Jamison BM, Alfieri C, Scherer S, Loertscher R: A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation. Br J Haematol 91:167, 1995
92. O'Riordan JM, Molloy K, O'Brian DS, Corbally N, Devaney D, McShane D, Considine N, McCann SR: Localized, late-onset, high-grade lymphoma following bone marrow transplantation: Response to combination chemotherapy. Br J Haematol 86:183, 1994
93. Trimble MS, Waye JS, Walker IR, Brain MC, Leber BF: B-cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T-cell acute lymphoblastic leukaemia. Br J Haematol 85:99, 1993
94. Schouten HC, Hopman AH, Haesevoets AM, Arends JW: Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation. Br J Haematol 91:162, 1995
95. Fialkow PJ, Thomas ED, Bryant JI, Neiman PE: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1:251, 1971
96. Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman P, Ramberg RE, Storb R: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1:1310, 1972
97. Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, Storb R, Thomas ED: Secondary malignancies after marrow transplantation. Exp Hematol 12:660, 1984
98. Boyd CN, Ramberg RE, Thomas ED: The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 6:833, 1982
99. Cornelius EA: Rapid viral induction of murine lymphomas in the graft-versus-host reaction. J Exp Med 136:1533, 1972
100. Schwartz RS: Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet 1:1266, 1972
101. Gleichmann E, Melief CJ, Gleichmann H: Lymphomagenesis and autoimmunization caused by reactions of T-lymphocytes to incompatible structures of the major histocompatibility complex: A concept of pathogenesis (review). Recent Results Cancer Res 64:292, 1978
102. Martin GM, Sprague CA: Parasexual cycle in cultivated human somatic cells. Science 166:761, 1969
103. Cornelius EA: Rapid immunological induction of murine lymphomas: Evidence for a viral etiology. Science 177:524, 1972
104. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765, 1982
105. Radich J: Detection of minimal residual disease in acute and chronic leukemias. Curr Opin Hematol 3:310, 1996
106. Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewicz JA, Thaler J, Huber C: Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 322:1794, 1990
107. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht, Cahn J, Harousseau J, Coiffier B, Biron P, Mandell F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540, 1995
108. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G, Stern AC, Magni M, Caracciolo D: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290, 1997
109. Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Briere J, Gaulard P, Reyes F: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 15:1131, 1997
110. Thirman MJ, Larson RA: Therapy-related myeloid leukemia (review). Hematol Oncol Clin North Am 10:293, 1996
111. Bennett JM: Secondary acute myeloid leukemia (editorial). Leuk Res 19:231, 1995
112. Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD Jr: Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol 14:565, 1996
113. Gale RE, Bunch C, Moir DJ, Patterson KG, Goldstone AH, Linch DC: Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns. Br J Haematol 93:53, 1996
114. Chao NJ, Nademanee AP, Long GD, Schmidt GM, Donlon TA, Parker P, Slovak ML, Nagasawa LS, Blume KG, Forman SJ: Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. J Clin Oncol 9:1575, 1991
115. Blume E: Secondary leukemias receive increased attention (news). J Natl Cancer Inst 87:336, 1995
116. Kumar L: Secondary leukaemia after autologous bone marrow transplantation. Lancet 345:810, 1995
117. Taylor P, Jackson GH, Lennard A, Hamilton PJ, Proctor SJ: Low frequency of myelodysplasia after autologous bone marrow transplantation (letter). Lancet 345:1248, 1995
118. Rohatiner A: Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation (editorial). J Clin Oncol 12:2521, 1994
119. Stone RM: Myelodysplastic syndrome after autologous transplantation for lymphoma: The price of progress? Blood 83:3437, 1994
120. Marolleau JP, Brice P, Morel P, Gisselbrecht C: Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas (letter). J Clin Oncol 11:590, 1993
121. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO: Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527, 1994
122. Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, Nadler LM: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535, 1994
123. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994
124. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ: Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:957, 1994
125. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ: Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma (review). Leuk Lymphoma 20:365, 1996
126. Andre M, Henry-Amar M, Blaise D, Colombat P, Fleury J, Milpied N, Cahn JY, Pico JL, Bastion Y, Kuentz M, Biron P, Ferme C, Gisselbrecht C: Incidence of second cancers (SC) and causes of death after autologous stem cell transplantation (ASCT) for Hodgkin's disease (HD). Blood 86:460a, 1995 (abstr, suppl 1)
127. Roman-Unfer S, Bitran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K: Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Bone Marrow Transplant 16:163, 1995
128. Govindarajan R, Jagannath S, Flick JT, Vesole DH, Sawyer J, Barlogie B, Tricot G: Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 95:349, 1996
129. + cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87:574, 1996
130. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H: Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187, 1994
131. Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R: Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 87:386, 1996
132. Kolb HJ, Duell T, Socié G, Van Lint MT, Carreras E, Tichelli A, Ljungman P, Jacobsen N, Apperley JF, Hertenstein B, Weiss M, Nekolla E, Goldstone AH: New malignancies in patients surviving more than 5 years after marrow transplantation. Blood 86:460a, 1995 (abstr, suppl 1)
133. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr, Schoch HG, Sale GE, Storb R, Travis WD, Kolb H-J, Gale RP, Passweg JR: Solid cancers after bone marrow transplantation. N Engl J Med 336:897, 1997
134. Donaldson SS, Hancock SL: Second cancers after Hodgkin's disease in childhood (editorial; comment). N Engl J Med 334:792, 1996